ING Groep N.V. : After the accumulation, an upward acceleration ?
Entry price | Target | Stop-loss | Potential |
---|
€12.81 |
€13.9 |
€12.15 |
+8.51% |
---|
From a horizontal accumulation phase, the timing seems good to buy shares in ING Groep N.V. and to get ahead of a break-out on the upside of the congestion area.
Summary● According to Refinitiv, the company's ESG score for its industry is good.
Strengths● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
● The company appears to be poorly valued given its net asset value.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● Over the past twelve months, analysts' consensus has been significantly revised downwards.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.